# Commission Implementing Decision of 11 December 2014 authorising the placing on the market of Clostridium butyricum (CBM 588) as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2014) 9345) (Only the English text is authentic) (2014/907/EU), Annex: SPECIFICATION OF CLOSTRIDIUM BUTYRICUM (CBM 588)

Extent: E+W+S+N.I.

Definition Clostridium butyricum (CBM 588) is a Gram-positive, spore-forming, obligate anaerobic, non-pathogenic, non-genetically modified bacterium.
Description White or pale grey tablets with characteristic odour and sweet taste.

---
Source: https://www.legislation.gov.uk/eudn/2014/907/annex (the official version)
Page: https://openlegislation.uk/eu-decision-2014-907/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.